# Excimer Laser With Topical Agents in Psoriasis Vulgaris

> **NCT05555797** · PHASE4 · UNKNOWN · sponsor: **Assiut University** · enrollment: 30 (estimated)

## Conditions studied

- Psoriasis

## Interventions

- **DEVICE:** 308nm Excimer laser
- **DRUG:** Tazarotene Topical Gel
- **DRUG:** Betamethasone Valerate

## Key facts

- **NCT ID:** NCT05555797
- **Lead sponsor:** Assiut University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-10-30
- **Primary completion:** 2023-09-30
- **Final completion:** 2023-09-30
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2022-10-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05555797

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05555797, "Excimer Laser With Topical Agents in Psoriasis Vulgaris". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT05555797. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*